Medication info
Pictomin Tablet

Pictomin Tablet

Prescription medicationTablet
Ingredient · strength
Pioglitazone Hydrochloride›16.53mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
경동제약(주)
Appearance
White to grayish-white, oblong, convex film-coated tablets
Packaging
28 tablets (7 tablets/Alu-Alu X 4)
Approval status
Active

MFDS item code 201706791 · Approved 2017.08.23 · Insurance code 648103990

Summary

Main use
Improvement in blood sugar control in type 2 diabetes
Who uses it
Adults
Adult dosage
The initial dose of this medicine should be based on the patient's current treatment regimen. 1. For patients whose blood sugar is not adequately controlled with metformin or pioglitazone monotherapy: the starting dose should be based on the current dosage of metformin or pioglitazone being taken. This medicine should be initiated at a dose of 1 tablet per day, with gradual dose adjustments based on the adequacy of treatment response. 2. For patients transitioning from a combination therapy of pioglitazone and metformin

Ingredients

Manufacturer
경동제약(주)

Efficacy & effects

Improvement in blood sugar control in type 2 diabetes

  • Insulin-resistant diabetes
  • blood sugar control issues
  • type 2 diabetes
View approved original text

This medicine is used in conjunction with dietary and exercise therapy to help patients with insulin-resistant diabetes control their blood sugar levels. It can be administered especially when blood sugar control is insufficient with pioglitazone or metformin alone. In addition, it is used as an alternative to the combination therapy with pioglitazone and metformin. Nutritional counseling, weight loss, and regular exercise are very important for managing type 2 diabetes, and using this medicine alongside these lifestyle modifications can enhance blood sugar control. This medicine improves diabetes treatment through effective blood sugar management.

Dosage and Administration

Adult dosage

The initial dose of this medicine should be based on the patient's current treatment regimen. 1. For patients whose blood sugar is not adequately controlled with metformin or pioglitazone monotherapy: the starting dose should be based on the current dosage of metformin or pioglitazone being taken. This medicine should be initiated at a dose of 1 tablet per day, with gradual dose adjustments based on the adequacy of treatment response. 2. For patients transitioning from a combination therapy of pioglitazone and metformin

Precautions

This medicine can cause severe lactic acidosis and hypoglycemia; if these symptoms occur, consult a doctor immediately. Lactic acidosis is a rare but very serious complication that carries a higher risk in patients with poor kidney function or heart disease. Regular checks on liver and kidney function should be conducted during treatment to ensure there are no abnormalities. Excessive alcohol intake may increase the risk of side effects from this medicine; therefore, it is advisable to avoid drinking. Patients with heart failure or severely impaired heart function should not take this medicine. Caution should be exercised when administering this medication to patients with a history of bladder cancer, and any symptoms such as hematuria or urination disorders should be reported to a doctor. Women who are pregnant or nursing should not take this medicine, and its safety has not been established in children. Older adults are at an increased risk of kidney function decline, so dose adjustments and regular function checks are necessary. During treatment, blood sugar and glycosylated hemoglobin levels should be monitored periodically to assess blood sugar control. Possible side effects include indigestion, diarrhea, headaches, edema, and weight gain; if symptoms are severe, consult healthcare professionals. If undergoing surgery or contrast tests, the use of this medicine should be stopped in advance, and resuming can occur only after confirming normal kidney function. There may be interactions with other medications, so it is essential to inform healthcare professionals of all medications being taken, especially when combined with drugs affecting kidney function.

Side effects and when to seek care immediately

Serious side effects

Severe lactic acidosis, hypoglycemia, severe allergic reactions (hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor), severe skin reactions (severe rashes with high fever, blisters, skin peeling, pain in oral/ocular mucosa), respiratory issues (shortness of breath or difficulty breathing, asthma attacks, cough with fever-induced respiratory issues), liver issues (yellowing of skin or eyes, systemic fatigue), severe neurological effects

Mild side effects

  • Upper respiratory infection
  • diarrhea
  • nausea
  • headache
  • urinary tract infection
  • sinusitis
  • dizziness
  • lower limb edema
  • weight gain
  • muscle pain
Show 14 more
  • dental disorders
  • worsening diabetes
  • pharyngitis
  • anemia
  • vitamin B12 reduction
  • indigestion
  • insomnia
  • dry mouth
  • constipation
  • abdominal bloating
  • gastroesophageal reflux disease
  • gastrointestinal air retention
  • increased serum creatinine
  • increased serum urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture and should be stored in a tightly sealed container. Avoid storing in extremely hot or cold places; it is best to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to grayish-white, oblong, convex film-coated tablets

Package unit

28 tablets (7 tablets/Alu-Alu X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.